Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384130180> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- W4384130180 abstract "BRAF is a key member in the MAPK signaling pathway essential for cell growth, proliferation, and differentiation. Dysregulation or mutation of BRAF is often the underlying cause of various types of cancer. RAS, a small GTPase protein that acts upstream of BRAF, has been identified as a driver of up to one-third of all cancers. When BRAF interacts with RAS via the RAS binding domain (RBD) and membrane recruitment, BRAF undergoes a conformational change from an inactive, autoinhibited monomer to an active dimer and subsequently phosphorylates MEK to propagate the signal. BRAF domains are involved in specific functions of the regulatory mechanism, as exampled by maintenance of the autoinhibited conformation through interactions between the Cysteine Rich Domain (CRD) and the Kinase Domain (KD) of BRAF. Despite the central role of BRAF in cellular signaling, the exact order and magnitude of its activation steps has yet to be confirmed experimentally. We employed pulldown assays, open surface plasmon resonance (OpenSPR), and hydrogen-deuterium exchange mass spectrometry (HDX-MS) to investigate the roles of the regulatory regions in BRAF activation and autoinhibition. Our results demonstrate that the BRAF specific region (BSR) and CRD play a crucial role in regulating the activity of BRAF. Moreover, we quantified the autoinhibitory binding affinities between the N-terminal domains of BRAF and the KD and revealed the individual roles of the BRAF regulatory domains. Furthermore, we quantified the relief of autoinhibition between the N-terminal domains of BRAF and the KD upon RAS binding, providing direct evidence that RAS binding initiates RAF activation. Additionally, our findings provide evidence that the BSR negatively regulates BRAF activation in a RAS isoform-specific manner and highlight the importance of considering the specific isoform pairs when developing inhibitors targeting RAF-RAS interactions. Our findings also indicate that oncogenic BRAF-KDD594G mutant has a lower affinity for the regulatory domains, implicating that pathogenic BRAF acts through decreased propensity for autoinhibition. Collectively, our study provides valuable insights into the activation mechanism of BRAF kinase and may help to guide the development of new therapeutic strategies for cancer treatment." @default.
- W4384130180 created "2023-07-14" @default.
- W4384130180 creator A5025286296 @default.
- W4384130180 date "2023-07-13" @default.
- W4384130180 modified "2023-09-24" @default.
- W4384130180 title "eLife assessment: Unveiling the Domain-Specific and RAS Isoform-Specific Details of BRAF Regulation" @default.
- W4384130180 doi "https://doi.org/10.7554/elife.88836.1.sa0" @default.
- W4384130180 hasPublicationYear "2023" @default.
- W4384130180 type Work @default.
- W4384130180 citedByCount "0" @default.
- W4384130180 crossrefType "peer-review" @default.
- W4384130180 hasAuthorship W4384130180A5025286296 @default.
- W4384130180 hasBestOaLocation W43841301801 @default.
- W4384130180 hasConcept C11960822 @default.
- W4384130180 hasConcept C184235292 @default.
- W4384130180 hasConcept C185592680 @default.
- W4384130180 hasConcept C207332259 @default.
- W4384130180 hasConcept C502942594 @default.
- W4384130180 hasConcept C55493867 @default.
- W4384130180 hasConcept C57074206 @default.
- W4384130180 hasConcept C62478195 @default.
- W4384130180 hasConcept C86803240 @default.
- W4384130180 hasConcept C95444343 @default.
- W4384130180 hasConceptScore W4384130180C11960822 @default.
- W4384130180 hasConceptScore W4384130180C184235292 @default.
- W4384130180 hasConceptScore W4384130180C185592680 @default.
- W4384130180 hasConceptScore W4384130180C207332259 @default.
- W4384130180 hasConceptScore W4384130180C502942594 @default.
- W4384130180 hasConceptScore W4384130180C55493867 @default.
- W4384130180 hasConceptScore W4384130180C57074206 @default.
- W4384130180 hasConceptScore W4384130180C62478195 @default.
- W4384130180 hasConceptScore W4384130180C86803240 @default.
- W4384130180 hasConceptScore W4384130180C95444343 @default.
- W4384130180 hasLocation W43841301801 @default.
- W4384130180 hasOpenAccess W4384130180 @default.
- W4384130180 hasPrimaryLocation W43841301801 @default.
- W4384130180 hasRelatedWork W1717645404 @default.
- W4384130180 hasRelatedWork W2002575458 @default.
- W4384130180 hasRelatedWork W2004726042 @default.
- W4384130180 hasRelatedWork W2015725807 @default.
- W4384130180 hasRelatedWork W2021872598 @default.
- W4384130180 hasRelatedWork W2025548430 @default.
- W4384130180 hasRelatedWork W2049982886 @default.
- W4384130180 hasRelatedWork W2091587849 @default.
- W4384130180 hasRelatedWork W2384817912 @default.
- W4384130180 hasRelatedWork W3035328115 @default.
- W4384130180 isParatext "false" @default.
- W4384130180 isRetracted "false" @default.
- W4384130180 workType "peer-review" @default.